Ladenburg Thalmann Initiates Coverage on Myriad Genetics (MYGN) with a Buy

March 2, 2010 1:16 PM EST Send to a Friend
Ladenburg Thalmann initiates coverage on Myriad Genetics (Nasdaq: MYGN) with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login